Drugs / AAVLP-HPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03929172 | Feb 2019 → May 2020 | human papilloma virus infection | 2A Pharma AB | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AAVLP-HPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03929172 ↗ |
| Modality | Vaccine | “adeno-associated virus-like particle human papillomavirus (AAVLP-HPV) vaccine” NCT03929172 ↗ |
| Route | Intramuscular | “for i.m. injection” NCT03929172 ↗ |